Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2019: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2018: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2017: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Outline of Final Research Achievements |
This study investigated the benefit of GLP-1 treatment on cardiovascular events in patients with type 2 diabetes mellitus, focusing on its effects on the stimulatory conduction system. Magnetocardiograms were performed before and 24 weeks after administration of GLP-1. No obvious changes were observed in various parameters before and after administration of GLP-1.Although this study did not elucidate the mechanism regarding the suppression of cardiovascular events, the suppression of cardiovascular events in diabetic patients is an important issue.
|